Bumetanide Injection
Product Images NDC 68462-470

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 68462-470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mlcarton (10mlcarton)

10mlcarton (10mlcarton)
Packaging label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) by Glenmark Pharmaceuticals Inc., USA. The label indicates the product is for intravenous or intramuscular use and comes in 10 x 10 mL multiple-dose vials. It includes storage instructions, ingredients, and a barcode.*
FDA Label Image

4mlcarton (4mlcarton)

4mlcarton (4mlcarton)
Packaging label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) single-dose vials. The label specifies the product is for intravenous or intramuscular use and is distributed by Glenmark Pharmaceuticals Inc., USA. The carton contains 10 vials of 4 mL each and includes storage instructions and ingredient details.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Bumetanide showing its molecular composition including a benzene ring with COOH, SO2NH2, OCH2CH3, and CH3(CH2)3HN substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.